版本:
中国

BRIEF-Aequus advances clinical development of Transdermal Aripiprazole Patch

Oct 17 Aequus Pharmaceuticals Inc

* Aequus advances clinical development of Transdermal Aripiprazole Patch

* Upon approval of CTA, Co plans to initiate repeat dose, 28-day safety, study of Aripiprazole Transdermal Patches in late 2016 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐